Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis
Titel:
Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis
Auteur:
Nakamura, T. Ito, M. Hashimoto, J. Shinomiya, K. Asao, Y. Katsumata, K. Hagino, H. Inoue, T. Nakano, T. Mizunuma, H.